SIRPγ limits effector differentiation of human CD8 T-cells in response to subthreshold TCR-signaling 2266789

Abstract Introduction Signal regulatory protein gamma (SIRPγ) is an immunomodulatory protein that is uniquely expressed on the cell surface of human T cells. Variants in the SIRPγ gene have been associated with type 1 diabetes, relapsing-remitting multiple sclerosis, and the maintenance of a long-term vaccine response. However, the mechanistic contribution of SIRPγ to inflammation remains unclear because its function in the immune system is not fully understood. Methods To investigate the functional role of SIRPγ in human CD8 T-cells, we performed siRNA-mediated knockdown in naïve human CD8+ T-cells. T-cell differentiation, effector responses, and cytokine production were studied by flow cytometry. A CD47 neutralization assay was performed to determine whether this known ligand is required for effector-like differentiation of naïve CD8 T-cells. Results We report that SIRPγ expression varies substantially across individuals and stratifies CD8+ T-cell differentiation states. Individuals with low SIRPγ expression exhibit an increased frequency of CD27⁻CD45RO+ effector-like and CD27⁻CD45RO⁻ terminally differentiated CD8+ T-cells, while high expressors retain a predominance of naïve and central memory cells. Under suboptimal TCR stimulation, SIRPG knockdown drove robust effector-like differentiation marked by increased CD45RO expression, T-bet upregulation, and enhanced production of TNF-α, IFN-γ, and Granzyme B. This phenotype was not recapitulated by CD47 blockade, indicating that SIRPγ modulates differentiation through a CD47-independent mechanism. Conclusion These findings identify SIRPγ as a negative regulator of CD8+ T-cell effector programming under limiting stimulatory conditions. Interindividual variability in SIRPγ expression may influence immune homeostasis and susceptibility to immunopathology, highlighting SIRPγ as a potential therapeutic target in settings of dysregulated T cell responses. Funding Source n/a Topic Categories Immune Response Regulation: Cellular Mechanisms (IRC)

Authors

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1108
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SIRPγ limits effector differentiation of human CD8 T-cells in response to subthreshold TCR-signaling 2266789

Sushmita Sinha, Megan Morse, Xanthie Rodriguez, Shanil Juma et al.
The Journal of Immunology
Phagocytosis and Immune Regulation
article

SIRPγ limits effector differentiation of human CD8 T-cells in response to subthreshold TCR-signaling 2266789

Sushmita Sinha, Megan Morse, Xanthie Rodriguez, Shanil Juma, Sierra Rodriguez, Erika Delarosa
article en

Abstract

Abstract Introduction Signal regulatory protein gamma (SIRPγ) is an immunomodulatory protein that is uniquely expressed on the cell surface of human T cells. Variants in the SIRPγ gene have been associated with type 1 diabetes, relapsing-remitting multiple sclerosis, and the maintenance of a long-term vaccine response. However, the mechanistic contribution of SIRPγ to inflammation remains unclear because its function in the immune system is not fully understood. Methods To investigate the functional role of SIRPγ in human CD8 T-cells, we performed siRNA-mediated knockdown in naïve human CD8+ T-cells. T-cell differentiation, effector responses, and cytokine production were studied by flow cytometry. A CD47 neutralization assay was performed to determine whether this known ligand is required for effector-like differentiation of naïve CD8 T-cells. Results We report that SIRPγ expression varies substantially across individuals and stratifies CD8+ T-cell differentiation states. Individuals with low SIRPγ expression exhibit an increased frequency of CD27⁻CD45RO+ effector-like and CD27⁻CD45RO⁻ terminally differentiated CD8+ T-cells, while high expressors retain a predominance of naïve and central memory cells. Under suboptimal TCR stimulation, SIRPG knockdown drove robust effector-like differentiation marked by increased CD45RO expression, T-bet upregulation, and enhanced production of TNF-α, IFN-γ, and Granzyme B. This phenotype was not recapitulated by CD47 blockade, indicating that SIRPγ modulates differentiation through a CD47-independent mechanism. Conclusion These findings identify SIRPγ as a negative regulator of CD8+ T-cell effector programming under limiting stimulatory conditions. Interindividual variability in SIRPγ expression may influence immune homeostasis and susceptibility to immunopathology, highlighting SIRPγ as a potential therapeutic target in settings of dysregulated T cell responses. Funding Source n/a Topic Categories Immune Response Regulation: Cellular Mechanisms (IRC)

The Journal of ImmunologyVol. 215(Supplement_1)
Good health and well-being
Openalex Percentile: Top 15%
Phagocytosis and Immune Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.